Login to Your Account



Acusphere Licenses AI-700 EU Rights to Nycomed For $70M

By Karen Pihl-Carey


Thursday, July 8, 2004
Retaining U.S. marketing rights for itself, Acusphere Inc. signed a deal with Nycomed Group for the European rights to its lead product, AI-700. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription